• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PPAR 编码基因的变异和表达变化与精神分裂症没有显著关联。

Variants and expression changes in PPAR-encoding genes display no significant association with schizophrenia.

机构信息

Department of Psychiatry, First Hospital /First Clinical Medical College of Shanxi Medical University, Taiyuan, China.

Department of Biomedical Engineering, Tianjin University, Tianjin, China.

出版信息

Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20201083.

DOI:10.1042/BSR20201083
PMID:32643760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7374279/
Abstract

A few studies suggested the contribution of PPARs to the etiology of schizophrenia (SCZ). However, it is still not clear whether variants in PPAR-encoding genes have a direct association with SCZ. The potential linkage between SCZ and the variants within PPAR encoding genes (PPARA, PPARD, and PPARG) was tested in a large cohort genome-wide association study (GWAS). Then, a mega-analysis was conducted using 14 gene expression profiling experiments in various human brain regions. Finally, the expression levels of the three PPAR-encoding genes were quantified in early-onset SCZ patients. Only one PPARG polymorphisms, rs62242085, presented a minor frequency deviation in the SCZ cohort (P-value = 0.035). None of the PPAR-encoding genes presented significant expression change within the brain regions profiled in 14 datasets acquired from different populations (P-value > 0.14) or in the whole blood of early-onset overall SCZ patients (P-value > 0.22). However, compared with healthy female controls, female early-onset SCZ patients presented a moderate but significant decrease in the expression level of PPARD (LFC = -0.55; P-value = 0.02) and a strong, but non-significant decrease in expression of PPARG (LFC = -1.30; P-value = 0.13). Our results do not support a significant association between variants in PPAR-encoding genes and SCZ, but suggest a necessity to explore the role of PPARD and PPARG in early SCZ phenotypes, specifically in females.

摘要

一些研究表明过氧化物酶体增殖物激活受体(PPARs)对精神分裂症(SCZ)的病因有一定的贡献。然而,PPAR 编码基因中的变体是否与 SCZ 有直接关联尚不清楚。在一项大规模的全基因组关联研究(GWAS)中,研究人员测试了 SCZ 与 PPAR 编码基因(PPARA、PPARD 和 PPARG)内变体之间的潜在联系。然后,使用来自不同人群的 14 个不同大脑区域的基因表达谱实验进行了 mega 分析。最后,在发病早的 SCZ 患者中定量检测了这三个 PPAR 编码基因的表达水平。只有一个 PPARG 多态性 rs62242085 在 SCZ 队列中表现出较小的频率偏差(P 值=0.035)。在从不同人群获得的 14 个数据集所分析的大脑区域内,没有一个 PPAR 编码基因表现出显著的表达变化(P 值>0.14),也没有在发病早的总体 SCZ 患者的全血中表现出显著的表达变化(P 值>0.22)。然而,与健康女性对照相比,发病早的女性 SCZ 患者的 PPARD 表达水平明显降低(LFC=-0.55;P 值=0.02),而 PPARG 的表达水平虽然较强,但无统计学意义降低(LFC=-1.30;P 值=0.13)。我们的研究结果不支持 PPAR 编码基因中的变体与 SCZ 之间存在显著关联,但表明有必要探索 PPARD 和 PPARG 在早期 SCZ 表型中的作用,特别是在女性中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/7374279/78b657a71382/bsr-40-bsr20201083-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/7374279/45aac33dbf82/bsr-40-bsr20201083-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/7374279/aa10fb99f7a5/bsr-40-bsr20201083-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/7374279/78b657a71382/bsr-40-bsr20201083-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/7374279/45aac33dbf82/bsr-40-bsr20201083-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/7374279/aa10fb99f7a5/bsr-40-bsr20201083-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a563/7374279/78b657a71382/bsr-40-bsr20201083-g3.jpg

相似文献

1
Variants and expression changes in PPAR-encoding genes display no significant association with schizophrenia.PPAR 编码基因的变异和表达变化与精神分裂症没有显著关联。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20201083.
2
Comprehensive analysis of peroxisome proliferator-activated receptors to predict the drug resistance, immune microenvironment, and prognosis in stomach adenocarcinomas.全面分析过氧化物酶体增殖物激活受体以预测胃腺癌的耐药性、免疫微环境和预后。
PeerJ. 2024 Mar 22;12:e17082. doi: 10.7717/peerj.17082. eCollection 2024.
3
Peroxisome proliferator-activated receptor (PPAR) isoforms are differentially expressed in peri-implantation porcine conceptuses.过氧化物酶体增殖物激活受体(PPAR)亚型在猪着床前的孕体中差异表达。
Theriogenology. 2017 Oct 1;101:53-61. doi: 10.1016/j.theriogenology.2017.06.013. Epub 2017 Jun 13.
4
PPARA, PPARD and PPARG gene polymorphisms in patients with unstable angina.不稳定型心绞痛患者中 PPARA、PPARD 和 PPARG 基因多态性。
Gene. 2019 Aug 30;711:143947. doi: 10.1016/j.gene.2019.143947. Epub 2019 Jun 25.
5
Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans.过氧化物酶体增殖物激活受体α和γ与小鼠的酒精摄入以及人类的戒酒和成瘾有关。
Alcohol Clin Exp Res. 2015 Jan;39(1):136-45. doi: 10.1111/acer.12610. Epub 2014 Dec 16.
6
Association of polymorphisms of peroxisome proliferator activated receptors in early and late onset of type 2 diabetes mellitus.2型糖尿病早发和晚发中过氧化物酶体增殖物激活受体多态性的关联
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S287-S293. doi: 10.1016/j.dsx.2017.03.004. Epub 2017 Mar 6.
7
The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.PPARD 和 PPARG 多态性对胶质瘤风险和预后的影响。
Sci Rep. 2020 Mar 20;10(1):5140. doi: 10.1038/s41598-020-60996-2.
8
Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.过氧化物酶体增殖物激活受体α、δ和γ基因多态性与冠心病风险的关联:一项病例对照研究及荟萃分析
Medicine (Baltimore). 2016 Aug;95(32):e4299. doi: 10.1097/MD.0000000000004299.
9
Gene-gene interactions among PPARα/δ/γ polymorphisms for hypertriglyceridemia in Chinese Han population.中国人群中 PPARα/δ/γ 多态性与高甘油三酯血症的基因-基因相互作用。
Gene. 2013 Feb 25;515(2):272-6. doi: 10.1016/j.gene.2012.11.078. Epub 2012 Dec 20.
10
Preterm and infection-driven preterm labor: the role of peroxisome proliferator-activated receptors and retinoid X receptor.早产及感染诱发的早产:过氧化物酶体增殖物激活受体和视黄酸 X 受体的作用。
Reproduction. 2009 Jun;137(6):1007-15. doi: 10.1530/REP-08-0496. Epub 2009 Mar 11.

引用本文的文献

1
Identification of important gene signatures in schizophrenia through feature fusion and genetic algorithm.通过特征融合和遗传算法鉴定精神分裂症中的重要基因特征。
Mamm Genome. 2024 Jun;35(2):241-255. doi: 10.1007/s00335-024-10034-7. Epub 2024 Mar 21.
2
Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer.揭开核受体在食管癌中功能作用的神秘面纱。
Int J Mol Sci. 2022 Sep 19;23(18):10952. doi: 10.3390/ijms231810952.
3
PPARα Signaling: A Candidate Target in Psychiatric Disorder Management.过氧化物酶体增殖物激活受体α 信号通路:精神障碍管理的候选靶点

本文引用的文献

1
Molecular pathway analysis associates alterations in obesity-related genes and antipsychotic-induced weight gain.分子通路分析将肥胖相关基因的改变与抗精神病药引起的体重增加联系起来。
Acta Neuropsychiatr. 2020 Apr;32(2):72-83. doi: 10.1017/neu.2019.41. Epub 2019 Nov 14.
2
Hippocampal Genetic Knockdown of PPARδ Causes Depression-Like Behaviors and Neurogenesis Suppression.海马体过表达 PPARδ 基因可导致抑郁样行为和神经发生抑制。
Int J Neuropsychopharmacol. 2019 Jun 3;22(6):372-382. doi: 10.1093/ijnp/pyz008.
3
Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications.
Biomolecules. 2022 May 20;12(5):723. doi: 10.3390/biom12050723.
PPAR 受体在不同疾病及其配体中的作用:生理重要性和临床意义。
Eur J Med Chem. 2019 Mar 15;166:502-513. doi: 10.1016/j.ejmech.2019.01.067. Epub 2019 Feb 1.
4
Common and Rare Genetic Risk Factors Converge in Protein Interaction Networks Underlying Schizophrenia.常见和罕见的遗传风险因素在精神分裂症潜在的蛋白质相互作用网络中汇聚。
Front Genet. 2018 Sep 28;9:434. doi: 10.3389/fgene.2018.00434. eCollection 2018.
5
Association of lifestyle-related factors and psychological factors on quality of life in people with schizophrenia.生活方式相关因素和心理因素与精神分裂症患者生活质量的关系。
Psychiatry Res. 2018 Sep;267:382-393. doi: 10.1016/j.psychres.2018.06.022. Epub 2018 Jun 18.
6
Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016.全球精神分裂症的流行病学和负担:来自 2016 年全球疾病负担研究的结果。
Schizophr Bull. 2018 Oct 17;44(6):1195-1203. doi: 10.1093/schbul/sby058.
7
Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential.吡格列酮,一种过氧化物酶体增殖物激活受体γ激动剂,可减少人类对尼古丁的渴望,对滥用潜力有轻微影响。
Pharmacol Biochem Behav. 2017 Dec;163:90-100. doi: 10.1016/j.pbb.2017.10.002. Epub 2017 Oct 8.
8
Genomic Editing of Non-Coding RNA Genes with CRISPR/Cas9 Ushers in a Potential Novel Approach to Study and Treat Schizophrenia.利用CRISPR/Cas9对非编码RNA基因进行基因组编辑开启了一种研究和治疗精神分裂症的潜在新方法。
Front Mol Neurosci. 2017 Feb 3;10:28. doi: 10.3389/fnmol.2017.00028. eCollection 2017.
9
An association between the PPARα-L162V polymorphism and nicotine dependency among patients with schizophrenia.PPARα-L162V 多态性与精神分裂症患者尼古丁依赖之间的关联。
Compr Psychiatry. 2016 Oct;70:118-24. doi: 10.1016/j.comppsych.2016.07.004. Epub 2016 Jul 9.
10
Localization of PPAR isotypes in the adult mouse and human brain.过氧化物酶体增殖物激活受体(PPAR)亚型在成年小鼠和人类大脑中的定位。
Sci Rep. 2016 Jun 10;6:27618. doi: 10.1038/srep27618.